XML 43 R30.htm IDEA: XBRL DOCUMENT v3.4.0.3
Valuation (Tables)
3 Months Ended
Mar. 31, 2016
Fair Value Disclosures [Abstract]  
Schedule Of Financial Instruments
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at March 31, 2016:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
50,000

 
$

 
$

 
$
50,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
989,334

 
$
22,306

 
$
1,011,640

U.S. Treasury securities
 

 
13,672

 

 
13,672

Private label residential mortgage-backed securities
 

 
110,333

 
113,382

 
223,715

Private label commercial mortgage-backed securities
 

 

 
35,350

 
35,350

Commercial mortgage loans
 

 

 
56,365

 
56,365

Residential mortgage loans
 

 

 
35,580

 
35,580

Collateralized loan obligations
 

 

 
34,415

 
34,415

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
143,854

 
143,854

Corporate debt
 

 

 
24,552

 
24,552

Real estate owned
 

 

 
21,843

 
21,843

Private corporate equity investments
 

 

 
24,599

 
24,599

Total investments, at fair value
 

 
1,113,339

 
512,246

 
1,625,585

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 

 

 
6,227

 
6,227

Credit default swaps on corporate bond indices
 

 
144,348

 

 
144,348

Credit default swaps on corporate bonds
 

 
114

 

 
114

Credit default swaps on asset-backed indices
 

 
21,311

 

 
21,311

Interest rate swaps
 

 
17,321

 

 
17,321

Total return swaps
 

 

 
1,074

 
1,074

Options
 

 
252

 

 
252

Futures
 
8

 

 

 
8

Warrants
 

 

 
100

 
100

Mortgage loan purchase commitments
 

 
43

 

 
43

Total financial derivatives–assets, at fair value
 
8

 
183,389

 
7,401

 
190,798

Repurchase agreements
 

 
127,468

 

 
127,468

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
8

 
$
1,424,196

 
$
519,647

 
$
1,943,851

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(571,063
)
 
$

 
$
(571,063
)
Government debt
 

 
(129,798
)
 

 
(129,798
)
Corporate debt
 

 

 
(3,029
)
 
(3,029
)
Common stock
 
(8,238
)
 

 

 
(8,238
)
Total investments sold short, at fair value
 
(8,238
)
 
(700,861
)
 
(3,029
)
 
(712,128
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(55,176
)
 

 
(55,176
)
Credit default swaps on corporate bonds
 

 
(776
)
 

 
(776
)
Credit default swaps on asset-backed indices
 

 
(1,330
)
 

 
(1,330
)
Credit default swaps on asset-backed securities
 

 

 
(220
)
 
(220
)
 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Interest rate swaps
 
$

 
$
(18,485
)
 
$

 
$
(18,485
)
Total return swaps
 

 
(129
)
 
(675
)
 
(804
)
Options
 

 
(6,589
)
 

 
(6,589
)
Futures
 
(377
)
 

 

 
(377
)
Forwards
 

 
(1,922
)
 

 
(1,922
)
Total financial derivatives–liabilities, at fair value
 
(377
)
 
(84,407
)
 
(895
)
 
(85,679
)
Guarantees(1)
 

 

 
(616
)
 
(616
)
Total investments sold short, financial derivatives–liabilities, securitized debt, and guarantees, at fair value
 
$
(8,615
)
 
$
(785,268
)
 
$
(4,540
)
 
$
(798,423
)
The table below reflects the value of the Company's Level 1, Level 2, and Level 3 financial instruments at December 31, 2015:
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
(In thousands)
Cash equivalents
 
$
160,000

 
$

 
$

 
$
160,000

Investments, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
1,035,662

 
$
24,918

 
$
1,060,580

Private label residential mortgage-backed securities
 

 
138,482

 
116,435

 
254,917

Private label commercial mortgage-backed securities
 

 

 
34,145

 
34,145

Commercial mortgage loans
 

 

 
66,399

 
66,399

Residential mortgage loans
 

 

 
22,089

 
22,089

Collateralized loan obligations
 

 

 
45,974

 
45,974

Consumer loans and asset-backed securities backed by consumer loans
 

 

 
115,376

 
115,376

Corporate debt
 

 

 
27,028

 
27,028

Real estate owned
 

 

 
12,522

 
12,522

Private corporate equity investments
 

 

 
22,088

 
22,088

Total investments, at fair value
 

 
1,174,144

 
486,974

 
1,661,118

 
 
 
 
 
 
 
 
 
Description
 
Level 1
 
Level 2
 
Level 3
 
Total
(continued)
 
(In thousands)
Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
 
$

 
$

 
$
6,332

 
$
6,332

Credit default swaps on corporate bond indices
 

 
137,643

 

 
137,643

Credit default swaps on corporate bonds
 

 
10

 

 
10

Credit default swaps on asset-backed indices
 

 
5,410

 

 
5,410

Interest rate swaps
 

 
9,943

 

 
9,943

Total return swaps
 

 

 
85

 
85

Options
 
112

 
2,050

 

 
2,162

Futures
 
32

 

 

 
32

Forwards
 

 
1,138

 

 
1,138

Warrants
 

 

 
150

 
150

Total financial derivatives–assets, at fair value
 
144

 
156,194

 
6,567

 
162,905

Repurchase agreements
 

 
105,700

 

 
105,700

Total investments and financial derivatives–assets, at fair value and repurchase agreements
 
$
144

 
$
1,436,038

 
$
493,541

 
$
1,929,723

Liabilities:
 
 
 
 
 
 
 
 
Investments sold short, at fair value-
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
 
$

 
$
(612,777
)
 
$

 
$
(612,777
)
Government debt
 

 
(114,051
)
 

 
(114,051
)
Corporate debt
 

 

 
(448
)
 
(448
)
Common stock
 
(1,471
)
 

 

 
(1,471
)
Total investments sold short, at fair value
 
(1,471
)
 
(726,828
)
 
(448
)
 
(728,747
)
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
Credit default swaps on corporate bond indices
 

 
(47,298
)
 

 
(47,298
)
Credit default swaps on corporate bonds
 

 
(683
)
 

 
(683
)
Credit default swaps on asset-backed indices
 

 
(365
)
 

 
(365
)
Credit default swaps on asset-backed securities
 

 

 
(221
)
 
(221
)
Interest rate swaps
 

 
(4,934
)
 

 
(4,934
)
Total return swaps
 

 

 
(4,662
)
 
(4,662
)
Options(2)
 

 
(1,760
)
 

 
(1,760
)
Futures
 
(528
)
 

 

 
(528
)
Forwards
 

 
(13
)
 

 
(13
)
Mortgage loan purchase commitments
 

 
(8
)
 

 
(8
)
Total financial derivatives–liabilities, at fair value
 
(528
)
 
(55,061
)
 
(4,883
)
 
(60,472
)
Guarantees(1)
 

 

 
(828
)
 
(828
)
Total investments sold short, financial derivatives–liabilities, securitized debt, and guarantees, at fair value
 
$
(1,999
)
 
$
(781,889
)
 
$
(6,159
)
 
$
(790,047
)

(1)
Included in Other liabilities on the Consolidated Statement of Assets, Liabilities, and Equity.
(2)
Conformed to current period presentation.
Schedule Of Significant Unobservable Inputs, Qualitative Information
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of December 31, 2015:
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
$
89,549

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
1.81

 
$
151.86

 
$
68.47

Collateralized loan obligations
41,978

 
Market Quotes
 
Non Binding Third-Party Valuation
 
13.00

 
102.00

 
84.84

Corporate debt and non-exchange traded corporate equity
18,972

 
Market Quotes
 
Non Binding Third-Party Valuation
 
3.00

 
200.00

 
77.85

Private label commercial mortgage-backed securities
20,365

 
Market Quotes
 
Non Binding Third-Party Valuation
 
6.07

 
73.20

 
41.28

Agency interest only residential mortgage-backed securities
21,067

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.97

 
22.41

 
11.08

Total return swaps
(4,577
)
 
Market Quotes
 
Non Binding Third-Party Valuation (1)
 
36.38

 
99.88

 
56.38

Private label residential mortgage-backed securities
26,886

 
Discounted Cash Flows
 
Yield
 
3.4
%
 
27.1
%
 
19.9
%
 
 
 
 
 
Projected Collateral Prepayments
 
5.4
%
 
74.6
%
 
46.3
%
 
 
 
 
 
Projected Collateral Losses
 
2.9
%
 
24.5
%
 
11.4
%
 
 
 
 
 
Projected Collateral Recoveries
 
0.3
%
 
13.0
%
 
8.0
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
8.6
%
 
88.6
%
 
34.3
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
13,780

 
Discounted Cash Flows
 
Yield
 
19.2
%
 
25.0
%
 
22.1
%
 
 
 
 
 
Projected Collateral Losses
 
0.7
%
 
2.3
%
 
1.6
%
 
 
 
 
 
Projected Collateral Recoveries
 
1.5
%
 
14.3
%
 
8.4
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
83.4
%
 
97.6
%
 
90.0
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and warrants
13,920

 
Discounted Cash Flows
 
Yield
 
15.0
%
 
20.0
%
 
16.2
%
Collateralized loan obligations
3,996

 
Discounted Cash Flows
 
Yield
 
8.3
%
 
20.6
%
 
13.5
%
 
 
 
 
 
Projected Collateral Prepayments
 
31.9
%
 
52.3
%
 
41.1
%
 
 
 
 
 
Projected Collateral Losses
 
2.6
%
 
17.3
%
 
12.9
%
 
 
 
 
 
Projected Collateral Recoveries
 
2.3
%
 
15.5
%
 
10.1
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
33.3
%
 
51.5
%
 
35.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans(2)
115,376

 
Discounted Cash Flows
 
Yield
 
9.0
%
 
15.0
%
 
10.4
%
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
40.9
%
 
30.9
%
 
 
 
 
 
Projected Collateral Losses
 
1.0
%
 
33.8
%
 
7.3
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
57.3
%
 
80.8
%
 
61.8
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
43,847

 
Discounted Cash Flows
 
Yield
 
9.8
%
 
17.6
%
 
11.9
%
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Non-performing commercial mortgage loans and commercial real estate owned
$
30,984

 
Discounted Cash Flows
 
Yield
 
10.2
%
 
19.4
%
 
13.7
%
 
 
 
 
 
Months to Resolution
 
4.0

 
24.0

 
9.3

Performing residential mortgage loans
13,848

 
Discounted Cash Flows
 
Yield
 
5.5
%
 
8.0
%
 
6.5
%
Non-performing residential mortgage loans and residential real estate owned
12,331

 
Discounted Cash Flows
 
Yield
 
5.7
%
 
7.9
%
 
7.3
%
 
 
 
 
 
Months to Resolution
 
3.4

 
113.6

 
20.6

Credit default swaps on asset-backed securities
6,111

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
26.6
%
 
44.1
%
 
32.6
%
 
 
 
 
 
Projected Collateral Losses
 
15.0
%
 
33.7
%
 
26.5
%
 
 
 
 
 
Projected Collateral Recoveries
 
6.8
%
 
16.9
%
 
12.0
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
24.5
%
 
33.1
%
 
28.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred equity investment in commercial mortgage-related private partnership
10,558

 
Discounted Cash Flows
 
Yield
 
14.0
%
 
16.5
%
 
14.7
%
 
 
 
 
 
Expected Holding Period (Months)
 
14.3

 
27.0

 
23.5

Agency interest only residential mortgage-backed securities
3,851

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(2)
 
441

 
1,672

 
622

 
 
 
 
 
Projected Collateral Prepayments
 
18.0
%
 
100.0
%
 
70.4
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
82.0
%
 
29.6
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entities
2,738

 
Enterprise Value
 
Equity Multiple(3)
 
2.7x

 
2.7x

 
2.7x

Non-exchange traded preferred and common equity investment in mortgage-related entities
2,630

 
Recent Transactions
 
Transaction Price
 
N/A

 
N/A

 
N/A

Guarantees
(828
)
 
Cash Flows
 
Expected Cash Flows(4)
 
N/A

 
N/A

 
N/A

(1)
Represents valuations on underlying assets.
(2)
Shown in basis points.
(3)
Represent an estimation of where market participants might value an enterprise.
(4)
Represents transactions with a remaining term of less than one year.
The following table identifies the significant unobservable inputs that affect the valuation of the Company's Level 3 assets and liabilities as of March 31, 2016:
 
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Private label residential mortgage-backed securities
$
75,404

 
Market Quotes
 
Non Binding Third-Party Valuation
 
$
1.88

 
$
153.12

 
$
66.93

Collateralized loan obligations
25,830

 
Market Quotes
 
Non Binding Third-Party Valuation
 
27.00

 
101.50

 
83.73

Corporate debt and non-exchange traded corporate equity
20,784

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.83

 
200.00

 
70.37

Private label commercial mortgage-backed securities
16,161

 
Market Quotes
 
Non Binding Third-Party Valuation
 
5.05

 
67.29

 
32.16

Agency interest only residential mortgage-backed securities
18,628

 
Market Quotes
 
Non Binding Third-Party Valuation
 
2.77

 
24.75

 
10.61

Total return swaps
399

 
Market Quotes
 
Non Binding Third-Party Valuation (1) 
 
16.31

 
100.38

 
94.29

Private label residential mortgage-backed securities
37,978

 
Discounted Cash Flows
 
Yield
 
4.4
%
 
13.0
%
 
11.6
%
 
 
 
 
 
Projected Collateral Prepayments
 
4.9
%
 
75.6
%
 
36.9
%
 
 
 
 
 
Projected Collateral Losses
 
4.4
%
 
25.6
%
 
12.9
%
 
 
 
 
 
Projected Collateral Recoveries
 
0.0
%
 
12.1
%
 
5.6
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
7.9
%
 
88.8
%
 
44.6
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Private label commercial mortgage-backed securities
19,189

 
Discounted Cash Flows
 
Yield
 
11.6
%
 
32.8
%
 
21.2
%
 
 
 
 
 
Projected Collateral Losses
 
0.6
%
 
2.4
%
 
1.2
%
 
 
 
 
 
Projected Collateral Recoveries
 
2.1
%
 
11.1
%
 
5.4
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
87.9
%
 
97.3
%
 
93.4
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Corporate debt and warrants
10,450

 
Discounted Cash Flows
 
Yield
 
0.0
%
 
15.3
%
 
14.8
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(continued)
Fair Value
 
Valuation 
Technique
 
Unobservable Input
 
Range
 
Weighted
Average
Description
 
 
 
Min
 
Max
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
Collateralized loan obligations
$
8,585

 
Discounted Cash Flows
 
Yield
 
10.5
%
 
66.5
%
 
18.8
%
 
 
 
 
 
Projected Collateral Prepayments
 
30.9
%
 
67.6
%
 
51.0
%
 
 
 
 
 
Projected Collateral Losses
 
1.4
%
 
19.2
%
 
7.1
%
 
 
 
 
 
Projected Collateral Recoveries
 
1.5
%
 
16.5
%
 
5.4
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
26.4
%
 
53.6
%
 
36.5
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Consumer loans and asset-backed securities backed by consumer loans
143,854

 
Discounted Cash Flows
 
Yield
 
9.0
%
 
25.0
%
 
10.3
%
 
 
 
 
 
Projected Collateral Prepayments
 
0.0
%
 
42.1
%
 
31.6
%
 
 
 
 
 
Projected Collateral Losses
 
1.0
%
 
33.8
%
 
7.6
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
56.1
%
 
80.7
%
 
60.8
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Performing commercial mortgage loans
30,189

 
Discounted Cash Flows
 
Yield
 
10.4
%
 
17.6
%
 
11.7
%
Non-performing commercial mortgage loans and commercial real estate owned
24,707

 
Discounted Cash Flows
 
Yield
 
10.2
%
 
28.3
%
 
15.5
%
 
 
 
 
 
Months to Resolution
 
3.0

 
39.8

 
18.7

Performing residential mortgage loans
28,877

 
Discounted Cash Flows
 
Yield
 
5.4
%
 
11.1
%
 
6.6
%
Non-performing residential mortgage loans and residential real estate owned
9,482

 
Discounted Cash Flows
 
Yield
 
6.5
%
 
11.4
%
 
8.7
%
 
 
 
 
 
Months to Resolution
 
3.4

 
120.2

 
24.8

Credit default swaps on asset-backed securities
6,007

 
Net Discounted Cash Flows
 
Projected Collateral Prepayments
 
27.2
%
 
50.3
%
 
33.4
%
 
 
 
 
 
Projected Collateral Losses
 
15.7
%
 
34.8
%
 
28.0
%
 
 
 
 
 
Projected Collateral Recoveries
 
6.4
%
 
15.0
%
 
10.6
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
23.1
%
 
32.0
%
 
28.0
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded equity investments in commercial mortgage-related private partnerships
10,435

 
Discounted Cash Flows
 
Yield
 
15.6
%
 
16.5
%
 
15.9
%
 
 
 
 
 
Expected Holding Period (Months)
 
11.5

 
24.5

 
20.8

Agency interest only residential mortgage-backed securities
3,678

 
Option Adjusted Spread ("OAS")
 
LIBOR OAS(2)
 
441

 
1,807

 
701

 
 
 
 
 
Projected Collateral Prepayments
 
20.3
%
 
100.0
%
 
64.1
%
 
 
 
 
 
Projected Collateral Scheduled Amortization
 
0.0
%
 
79.7
%
 
35.9
%
 
 
 
 
 
 
 
 
 
 
 
100.0
%
Non-exchange traded preferred and common equity investment in mortgage-related entities
2,053

 
Enterprise Value
 
Equity Multiple(3)
 
1.9x
 
1.9x
 
1.9x
Commercial mortgage loans and REO
20,533

 
Recent Transactions
 
Contract Price
 
44.29
 
95.08
 
64.25
Non-exchange traded preferred and common equity investment in mortgage-related entities
2,500

 
Recent Transactions
 
Transaction Price
 
N/A
 
N/A
 
N/A
Guarantees
(616
)
 
Cash Flows
 
Expected Cash Flows(4)
 
N/A
 
N/A
 
N/A
(1)
Represents valuations on underlying assets.
(2)
Shown in basis points.
(3)
Represent an estimation of where market participants might value an enterprise.
(4)
Represents transactions with a remaining term of less than one year.
Fair Value Measurement Using Significant Unobservable Inputs
The tables below include a roll-forward of the Company's financial instruments for the three month periods ended March 31, 2016 and 2015 (including the change in fair value), for financial instruments classified by the Company within Level 3 of the valuation hierarchy.
Level 3—Fair Value Measurement Using Significant Unobservable Inputs:
Three Month Period Ended March 31, 2016
(In thousands)
Ending
Balance as of 
December 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
March 31, 2016
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
24,918

 
$
(2,057
)
 
$
(9
)
 
$
(546
)
 
$

 
$

 
$

 
$

 
$
22,306

Private label residential mortgage-backed securities
116,435

 
605

 
313

 
(1,709
)
 
5,731

 
(4,943
)
 
12,070

 
(15,120
)
 
113,382

Private label commercial mortgage-backed securities
34,145

 
455

 
322

 
(3,000
)
 
7,844

 
(4,416
)
 

 

 
35,350

Commercial mortgage loans
66,399

 
546

 
183

 
893

 
13,424

 
(25,080
)
 

 

 
56,365

Residential mortgage loans
22,089

 
107

 
108

 
275

 
14,965

 
(1,964
)
 

 

 
35,580

Collateralized loan obligations
45,974

 
(927
)
 
1,080

 
272

 

 
(11,984
)
 

 

 
34,415

Consumer loans and asset-backed securities backed by consumer loans
115,376

 
(2,882
)
 

 
105

 
51,910

 
(20,655
)
 

 

 
143,854

Corporate debt
27,028

 
113

 
(20
)
 
(3,975
)
 
2,967

 
(1,561
)
 

 

 
24,552

Real estate owned
12,522

 

 
260

 
1,419

 
9,788

 
(2,146
)
 

 

 
21,843

Private corporate equity investments
22,088

 

 
(130
)
 
(1,228
)
 
3,927

 
(58
)
 

 

 
24,599

Total investments, at fair value
486,974

 
(4,040
)
 
2,107

 
(7,494
)
 
110,556

 
(72,807
)
 
12,070

 
(15,120
)
 
512,246

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
6,332

 

 
91

 
(105
)
 
36

 
(127
)
 

 

 
6,227

Total return swaps
85

 

 
(3,515
)
 
989

 
3,568

 
(53
)
 

 

 
1,074

Warrants
150

 

 
(50
)
 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
6,567

 

 
(3,474
)
 
884

 
3,604

 
(180
)
 

 

 
7,401

Total investments and financial derivatives–assets, at fair value
$
493,541

 
$
(4,040
)
 
$
(1,367
)
 
$
(6,610
)
 
$
114,160

 
$
(72,987
)
 
$
12,070

 
$
(15,120
)
 
$
519,647

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments sold short, at fair value
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate debt
$
(448
)
 
$
1

 
$
360

 
$
(249
)
 
$
887

 
$
(3,580
)
 
$

 
$

 
$
(3,029
)
Total investments sold short, at fair value
(448
)
 
1

 
360

 
(249
)
 
887

 
(3,580
)
 

 

 
(3,029
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(In thousands)
Ending
Balance as of 
December 31, 2015
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of 
March 31, 2016
(continued)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives–liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(221
)
 
$

 
$
(16
)
 
$
1

 
$

 
$
16

 
$

 
$

 
$
(220
)
Total return swaps
(4,662
)
 

 
(2,251
)
 
3,988

 
2,337

 
(87
)
 

 

 
(675
)
Total financial derivatives– liabilities, at fair value
(4,883
)
 

 
(2,267
)
 
3,989

 
2,337

 
(71
)
 

 

 
(895
)
Guarantees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Guarantees
(828
)
 

 

 
212

 

 

 

 

 
(616
)
Total guarantees
(828
)
 

 

 
212

 

 

 

 

 
(616
)
Total investments sold short, financial derivatives– liabilities, securitized debt, and guarantees, at fair value
$
(6,159
)
 
$
1

 
$
(1,907
)
 
$
3,952

 
$
3,224

 
$
(3,651
)
 
$

 
$

 
$
(4,540
)
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at March 31, 2016, as well as Level 3 financial instruments disposed of by the Company during the three month period ended March 31, 2016. For Level 3 financial instruments held by the Company at March 31, 2016, change in net unrealized gain (loss) of $(7.7) million, $3.6 million, $0.6 million, and $0.2 million, for the three month period ended March 31, 2016 relate to investments, financial derivatives–assets, financial derivatives–liabilities, and guarantees, respectively.
As of March 31, 2016, the Company transferred $15.1 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, as of March 31, 2016, the Company transferred $12.1 million of non-Agency RMBS from Level 2 to Level 3. Since December 31, 2015, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.
Three Month Period Ended March 31, 2015
(In thousands)
Ending
Balance as of December 31, 2014
 
Accreted
Discounts /
(Amortized
Premiums)
 
Net Realized
Gain/
(Loss)
 
Change in
Net
Unrealized
Gain/(Loss)
 
Purchases/
Payments
 
Sales/
Issuances
 
Transfers Into Level 3
 
Transfers Out of Level 3
 
Ending
Balance as of March 31, 2015
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Investments, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Agency residential mortgage-backed securities
$
31,385

 
$
(2,006
)
 
$
471

 
$
(96
)
 
$
1,190

 
$
(4,609
)
 
$

 
$

 
$
26,335

Private label residential mortgage-backed securities
274,369

 
2,388

 
1,206

 
3,062

 
6,633

 
(39,423
)
 
23,221

 
(102,085
)
 
169,371

Private label commercial mortgage-backed securities
53,311

 
1,372

 
614

 
(1,900
)
 
15,594

 
(16,777
)
 

 

 
52,214

Commercial mortgage loans
28,309

 
539

 

 
17

 
24,291

 
(14,238
)
 

 

 
38,918

Residential mortgage loans
27,482

 
443

 
242

 
144

 
5,976

 
(3,442
)
 

 

 
30,845

Collateralized loan obligations(1)
121,994

 
(4,626
)
 
772

 
(1,701
)
 
10,477

 
(38,086
)
 

 

 
88,830

Consumer loans and asset-backed securities backed by consumer loans(1)
24,294

 
(1,714
)
 

 
547

 
16,057

 
(4,394
)
 

 

 
34,790

Corporate debt
42,708

 
31

 
186

 
(580
)
 
11,605

 
(22,114
)
 

 

 
31,836

Real estate owned
8,635

 

 
84

 
537

 
2,471

 
(2,657
)
 

 

 
9,070

Private corporate equity investments
14,512

 

 

 
230

 
6,572

 
(14
)
 

 

 
21,300

Total investments, at fair value
626,999

 
(3,573
)
 
3,575

 
260

 
100,866

 
(145,754
)
 
23,221

 
(102,085
)
 
503,509

Financial derivatives–assets, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
11,387

 
$

 
$
401

 
$
(355
)
 
$
22

 
$
(646
)
 
$

 
$

 
$
10,809

Total return swaps

 

 

 
118

 

 

 

 

 
118

Warrants
100

 

 

 

 

 

 

 

 
100

Total financial derivatives– assets, at fair value
11,487

 

 
401

 
(237
)
 
22

 
(646
)
 

 

 
11,027

Total investments and financial derivatives–assets, at fair value
$
638,486

 
$
(3,573
)
 
$
3,976

 
$
23

 
$
100,888

 
$
(146,400
)
 
$
23,221

 
$
(102,085
)
 
$
514,536

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Financial derivatives– liabilities, at fair value-
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Credit default swaps on asset-backed securities
$
(239
)
 
$

 
$
(19
)
 
$

 
$

 
$
19

 
$

 
$

 
$
(239
)
Total return swaps

 

 

 
(307
)
 

 

 

 

 
(307
)
Total financial derivatives– liabilities, at fair value
(239
)
 

 
(19
)
 
(307
)
 

 
19

 

 

 
(546
)
Securitized debt:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Securitized debt
(774
)
 
(2
)
 

 
19

 
88

 

 

 

 
(669
)
Total securitized debt
(774
)
 
(2
)
 

 
19

 
88

 

 

 

 
(669
)
Total financial derivatives– liabilities and securitized debt, at fair value
$
(1,013
)
 
$
(2
)
 
$
(19
)
 
$
(288
)
 
$
88

 
$
19

 
$

 
$

 
$
(1,215
)

(1)
Conformed to prior period presentation.
All amounts of net realized and change in net unrealized gain (loss) in the table above are reflected in the accompanying Consolidated Statement of Operations. The table above incorporates changes in net unrealized gain (loss) for both Level 3 financial instruments held by the Company at March 31, 2015, as well as Level 3 financial instruments disposed of by the Company during the three month period ended March 31, 2015. For Level 3 financial instruments held by the Company at March 31, 2015, change in net unrealized gain (loss) of $(3.2) million, $(0.2) million, $(0.3) million, and $19 thousand for the three month period ended March 31, 2015 relate to investments, financial derivatives–assets, financial derivatives–liabilities, and securitized debt, respectively.
As of March 31, 2015, the Company transferred $102.1 million of non-Agency RMBS from Level 3 to Level 2. These assets were transferred from Level 3 to Level 2 based on an increased volume of observed trading of these and similar assets. This increase in observed trading activity has led to greater price transparency for these assets, thereby making a Level 2 designation appropriate in the Company's view. However, changes in the volume of observable inputs for these assets, such as a decrease in the volume of observed trading, could impact price transparency, and thereby cause a change in the level designation for these assets in future periods.
In addition, as of March 31, 2015, the Company transferred $23.2 million of non-Agency RMBS from Level 2 to Level 3. Following December 2014, these securities have exhibited indications of a reduced level of price transparency. Examples of such indications include wider spreads relative to similar securities and a reduction in observable transactions involving these and similar securities. Changes in these indications could impact price transparency, and thereby cause a change in the level designation in future periods.